Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
Prospective Evaluation of Single Cell Mutations in a Panel of Known Oncogenes in NSCLC Surgical Specimens
- Status
- RECRUITING
- Phase
- N/A
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
BBP-398 in Combination With Osimertinib in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutations
- Status
- TERMINATED
- Phase
- PHASE1
Neratinib Tablets in the Treatment of Advanced NSCLC With Rare EGFR Mutations
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
The Efficacy and Safety of KN046 Combined With Axitinib
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Folinic Acid for Prevention of Pemetrexed-induced Toxicity
- Status
- UNKNOWN
- Phase
- PHASE4
Antitumor Activity and Safety of BEBT-109, a Novel EGFR Inhibitor, in Previously Treated NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
99mTc-H7ND SPECT/CT Imaging in NSCLC
- Status
- RECRUITING
- Phase
- NA
IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Real-World Study of Atezolizumab in Combination With Platinum-Based Doublet Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-IIIB NSCLC
- Status
- RECRUITING
- Phase
- N/A
A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Trial of Pulsed Electric Field Therapy in Patients With Late-stage Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- NA
EGFR_IUO 3.20 Clinical Study Protocol
- Status
- WITHDRAWN
- Phase
- NA
TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
Study of LP-184 in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Apatinib and Fluzoparib With or Without Adebrelimab in Previously-treated TP53-mutant Advanced Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- N/A